Aldo Caltavituro

3PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 07, 2026
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study.

|Mar 06, 2026
Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Roberto Buonaiuto, Aldo Caltavituro, Rossana Di Rienzo

|May 16, 2023
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention.

Roberto Buonaiuto, Giuseppe Neola, Sabrina Chiara Cecere

Pageof 1

Frequent Collaborators

1 joint publications

Roberto Buonaiuto

1 joint publications

Rossana Di Rienzo

1 joint publications

Martina Pagliuca

1 joint publications

Giuseppe Buono